TB Archives – Page 25 of 48 – Treatment Action Group

White House and Congress Must Boldly Address Drug Pricing and Ensure Access to Critical HIV, HCV, and TB Medications

July 16, 2018
Chad Cipiti

Treatment Action Group (TAG), NASTAD (National Alliance of State & Territorial AIDS Directors) and HIVMA (HIV Medicine Association join together in submitting collaborative comments today in response to the Department of Health and Human Services (HHS) public request for information (RFI) on the agency’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

TB Research Briefing for UN Mission: Vital Role of Research for TB Elimination

July 5, 2018
Chad Cipiti

TB Research Briefing for UN Missions: THE VITAL ROLE OF RESEARCH FOR TB ELIMINATION This briefing in New York City on June 4, 2018 provided an opportunity for discussion on the importance of investing in the full spectrum of TB…

TAG Welcomes Price Reductions for TB Medicines

June 19, 2018
Chad Cipiti

Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.

TAGline Spring 2018

April 10, 2018
Chad Cipiti

Bend the Curves: Incremental change—activism that successfully defends or advances critical research or policy—can sometimes feel inconsequential, particularly when it is hard won, resource intensive, and intangible.

Combating Rising Tuberculosis in New York

April 9, 2018
Chad Cipiti

As unbelievable as it sounds in 2018, despite being preventable and curable Tuberculosis (TB) is on the rise in New York City for the first time in 25 years. Cases of drug-resistant TB, which are much more difficult and costly…

In a State of Disunion: HIV, TB, and HCV Elimination Policies and Priorities Under the Trump Administration

April 3, 2018
Chad Cipiti

By Suraj Madoori During Trump’s first-ever State of the Union address on January 30, activists observed a dearth of clear priorities to eliminate HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV) in the U.S. Science and longstanding bipartisan interest in…

New York Community Groups Call on City, State, Federal Actors to Increase Funding for Tuberculosis

March 22, 2018
Chad Cipiti

Advocates alarmed that budget cuts led to first rise in TB cases in New York City in over 25 years.

It’s Time to Deliver – Including Pregnant and Lactating Women in Clinical Research

February 6, 2018
Chad Cipiti

Pregnant women have frequently been excluded from or de-prioritized in clinical research initiatives due to a multitude of factors, such as the complex physiology of pregnant women, the risk studies may pose to the fetus, and the classification of pregnant…

World Health Organization Guidelines for the Treatment of Multidrug-Resistant Tuberculosis

February 1, 2018
Dorrit Walsh

Letter to Dr. Tedros Adhanom Ghebreyesus, Director-General, WHO, and Dr. Tereza Kasaeva, Global TB Program Director.

Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide

January 31, 2018
Chad Cipiti

August 23, 2019 –This guide is for people who have tuberculosis (TB), people who are at risk for it, and the people who take care of them. It explains what global standards are for TB prevention, treatment, and care, so…